These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34901237)

  • 1. Association Between Long-Term Visit-to-Visit Hemoglobin A1c and Cardiovascular Risk in Type 2 Diabetes: The ACCORD Trial.
    Huang D; Huang YQ; Zhang QY; Cui Y; Mu TY; Huang Y
    Front Cardiovasc Med; 2021; 8():777233. PubMed ID: 34901237
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study.
    Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W;
    J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA
    Wang JM; Miao MY; Jia YP; Wang XW; Wu XB; Wan ZX; Zheng Y; Qin LQ; Li FR; Chen GC
    Diabetes Res Clin Pract; 2024 Feb; 208():111100. PubMed ID: 38246509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Long-term HbA
    Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
    Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
    Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ
    Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus.
    Long C; Tang Y; Huang J; Liu S; Xing Z
    Front Endocrinol (Lausanne); 2022; 13():975468. PubMed ID: 36034445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.
    Sato M; Inaishi J; Saisho Y; Sato Y; Komuro I; Itoh H
    J Diabetes Investig; 2021 Dec; 12(12):2190-2196. PubMed ID: 34013644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-Visit Variability of Hemoglobin A
    Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
    Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint effect of visit-to-visit variability in LDL-cholesterol, HDL-cholesterol and HbA1c on cardiovascular and total mortality in patients with diabetes.
    He P; Gan X; Wu Q; Ye Z; Yang S; Zhang Y; Li H; Zhou C; Zhang Y; Liu M; Qin X
    Diabetol Metab Syndr; 2022 Sep; 14(1):132. PubMed ID: 36123712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.
    Segar MW; Patel KV; Vaduganathan M; Caughey MC; Butler J; Fonarow GC; Grodin JL; McGuire DK; Pandey A
    Diabetes Care; 2020 Aug; 43(8):1920-1928. PubMed ID: 32540922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Long-Term HbA1c Variability and Functional Limitation in Individuals Aged Over 50 Years: A Retrospective Cohort Study.
    Shao D; Wang SS; Sun JW; Wang HP; Sun Q
    Front Endocrinol (Lausanne); 2022; 13():847348. PubMed ID: 35574024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes.
    Yeh ST; Ooi SW; Chang YH; Li CY; Chen HF
    Medicine (Baltimore); 2022 Aug; 101(33):e29942. PubMed ID: 35984136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control.
    Alatorre CI; Hoogwerf BJ; Deeg MA; Nelson DR; Hunter TM; Ng WT; Rekhter MD
    Curr Med Res Opin; 2018 Feb; 34(2):337-343. PubMed ID: 29065729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hemoglobin A1c Trajectories on Future Outcomes in a 10-Year Cohort With Type 2 Diabetes Mellitus.
    Ma C; Zhang W; Xie R; Wan G; Yang G; Zhang X; Fu H; Zhu L; Lv Y; Zhang J; Li Y; Ji Y; Gao D; Cui X; Wang Z; Chen Y; Yuan S; Yuan M
    Front Endocrinol (Lausanne); 2022; 13():846823. PubMed ID: 35450420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study.
    Muntner P; Whittle J; Lynch AI; Colantonio LD; Simpson LM; Einhorn PT; Levitan EB; Whelton PK; Cushman WC; Louis GT; Davis BR; Oparil S
    Ann Intern Med; 2015 Sep; 163(5):329-38. PubMed ID: 26215765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Both Short-term and Long-term Glycemic Variability With the Development of Microalbuminuria in the ACCORD Trial.
    Okuno T; Vansomphone A; Zhang E; Zhou H; Koska J; Reaven P; Zhou JJ
    Diabetes; 2023 Dec; 72(12):1864-1869. PubMed ID: 37725902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visit to Visit Hemoglobin A1c Variation and Long-term Risk of Major Adverse Limb Events in Patients With Type 2 Diabetes.
    Hsiao FC; Chan YH; Tung YC; Lin CP; Lee TH; Wang YC; Chu PH
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2500-2509. PubMed ID: 37022983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Liu X; Wu S; Song Q; Wang X
    Atherosclerosis; 2020 Nov; 312():110-116. PubMed ID: 32958454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study.
    Pei J; Wang X; Pei Z; Hu X
    Cardiovasc Diabetol; 2023 Oct; 22(1):287. PubMed ID: 37891565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
    Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.